Abstract

BackgroundMore than 3 million infections were attributed to Chikungunya virus (CHIKV) in the 2014–2016 outbreak in Mexico, Central and South America, with over 500 deaths directly or indirectly related to this viral disease. CHIKV outbreaks are recurrent and no vaccine nor approved therapeutics exist to prevent or treat CHIKV infection. Reliable and robust diagnostic methods are thus critical to control future CHIKV outbreaks. Direct CHIKV detection in serum samples via highly specific and high affinity anti-CHIKV antibodies has shown to be an early and effective clinical diagnosis.MethodsTo isolate highly specific and high affinity anti-CHIKV, Chikungunya virions were isolated from serum of a patient in Veracruz, México. After purification and characterization via electron microscopy, SDS-PAGE and binding to well-characterized anti-CHIKV antibodies, UV-inactivated particles were utilized as selector in a solid-phase panning in combination with ALTHEA Gold Libraries™, as source of antibodies. The screening was based on ELISA and Next-Generation Sequencing.ResultsThe CHIKV isolate showed the typical morphology of the virus. Protein bands in the SDS-PAGE were consistent with the size of CHIKV capsid proteins. UV-inactivated CHIKV particles bound tightly the control antibodies. The lead antibodies here obtained, on the other hand, showed high expression yield, > 95% monomeric content after a single-step Protein A purification, and importantly, had a thermal stability above 75 °C. Most of the antibodies recognized linear epitopes on E2, including the highest affinity antibody called C7. A sandwich ELISA implemented with C7 and a potent neutralizing antibody isolated elsewhere, also specific for E2 but recognizing a discontinuous epitope, showed a dynamic range of 0.2–40.0 mg/mL of UV-inactivated CHIKV purified preparation. The number of CHIKV particles estimated based on the concentration of E2 in the extract suggested that the assay could detect clinically meaningful amounts of CHIKV in serum.ConclusionsThe newly discovered antibodies offer valuable tools for characterization of CHIKV isolates. Therefore, the strategy here followed using whole viral particles and ALTHEA Gold Libraries™ could expedite the discovery and development of antibodies for detection and control of emergent and quickly spreading viral outbreaks.

Highlights

  • More than 3 million infections were attributed to Chikungunya virus (CHIKV) in the 2014–2016 out‐ break in Mexico, Central and South America, with over 500 deaths directly or indirectly related to this viral disease

  • Detection methods of CHIKV infection are based on virus isolation, reverse transcriptase polymerase chain reaction (RT-PCR) [16] and IgM/IgG Enzyme-Linked ImmunoSorbent Assay (ELISA) [17]

  • Some of the tests relies on anti-CHIKV monoclonal antibodies obtained via hybridoma technology after immunization with inactivated CHIKV particles or recombinant proteins derived from the virus [12, 20]

Read more

Summary

Introduction

More than 3 million infections were attributed to Chikungunya virus (CHIKV) in the 2014–2016 out‐ break in Mexico, Central and South America, with over 500 deaths directly or indirectly related to this viral disease. Other symptoms include abrupt fever, muscle pain, headache, nausea, fatigue, and rash These symptoms are often mild, and the infection may go unrecognized or not accurately diagnosed, in regions where other infections caused by Dengue virus (DENV) and Zika virus (ZIKV) occur. The first CHIKV report in Mexico occurred in May 2014 from a patient in Jalisco, who showed CHIKV infection symptoms after a trip to the Caribbean region [4]. More than three million CHIKV infections have been reported in Mexico, Central and South America, with over 500 deaths directly or indirectly related to this viral disease [8]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.